{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:14:33Z","timestamp":1792599273304,"version":"4.5.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"24","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":1323,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.jacc.2009.09.010","type":"journal-article","created":{"date-parts":[[2009,12,2]],"date-time":"2009-12-02T05:00:10Z","timestamp":1259730010000},"page":"2290-2295","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":108,"title":["Effect of Intensive Statin Therapy on Clinical Outcomes Among Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome"],"prefix":"10.1016","volume":"54","author":[{"given":"C. Michael","family":"Gibson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri B.","family":"Pride","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia P.","family":"Hochberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Sloan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc S.","family":"Sabatine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"Cannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2009.09.010_bib1","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2009.09.010_bib2","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jama.285.13.1711","article-title":"Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial","volume":"285","author":"Schwartz","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2009.09.010_bib3","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jama.292.11.1307","article-title":"Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes","volume":"292","author":"de Lemos","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2009.09.010_bib4","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","article-title":"Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines","volume":"110","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2009.09.010_bib5","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/01.hco.0000181482.99067.bf","article-title":"The pleiotropic effects of statins","volume":"20","author":"Calabro","year":"2005","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.jacc.2009.09.010_bib6","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.jacc.2005.05.086","article-title":"The potential relevance of the multiple lipid-independent (pleiotropic) effects of statins in the management of acute coronary syndromes","volume":"46","author":"Ray","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2009.09.010_bib7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijcard.2005.05.056","article-title":"Effects of statins beyond lipid lowering: potential for clinical benefits","volume":"109","author":"Almuti","year":"2006","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2009.09.010_bib8","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S0002-9149(02)02201-4","article-title":"Design of the Pravastatin or Atorvastatin Evaluation and Infection Therapy (PROVE IT)-TIMI 22 trial","volume":"89","author":"Cannon","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2009.09.010_bib9","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1161\/CIRCULATIONAHA.105.586347","article-title":"A tale of two trials: a comparison of the post-acute coronary syndrome lipid trials A to Z and PROVE IT-TIMI 22","volume":"113","author":"Wiviott","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2009.09.010_bib10","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1001\/jama.287.24.3215","article-title":"Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial","volume":"287","author":"Serruys","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2009.09.010_bib11","doi-asserted-by":"crossref","unstructured":"Johnson C, Waters DD, DeMicco DA, et al. Comparison of effectiveness of atorvastatin 10 mg versus 80 mg in reducing major cardiovascular events and repeat revascularization in patients with previous percutaneous coronary intervention (post hoc analysis of the Treating to New Targets [TNT] study). 2008;102:1312\u20137.","DOI":"10.1016\/j.amjcard.2008.07.023"},{"key":"10.1016\/j.jacc.2009.09.010_bib12","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jacc.2007.10.002","volume":"51","author":"King","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2009.09.010_bib13","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/j.amjcard.2006.09.016","article-title":"Beyond lipid lowering: what have we learned about the benefits of statins from the acute coronary syndromes trials?","volume":"98","author":"Ray","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2009.09.010_bib14","doi-asserted-by":"crossref","first-page":"54F","DOI":"10.1016\/j.amjcard.2005.06.027","article-title":"Early time to benefit with intensive statin treatment: could it be the pleiotropic effects?","volume":"96","author":"Ray","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2009.09.010_bib15","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1161\/CIRCULATIONAHA.108.773747","article-title":"Effect of rosuvastatin therapy on coronary artery stenoses assessed by quantitative coronary angiography: a study to evaluate the effect of rosuvastatin on intravascular ultrasound-derived coronary atheroma burden","volume":"117","author":"Ballantyne","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2009.09.010_bib16","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jama.297.12.1344","article-title":"Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR trial","volume":"297","author":"Crouse","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2009.09.010_bib17","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1001\/jama.295.13.jpc60002","article-title":"Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial","volume":"295","author":"Nissen","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2009.09.010_bib18","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1001\/jama.291.9.1071","article-title":"Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial","volume":"291","author":"Nissen","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2009.09.010_bib19","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1161\/01.CIR.0000140261.58966.A4","article-title":"Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH study","volume":"110","author":"Okazaki","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2009.09.010_bib20","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.amjcard.2006.09.017","article-title":"Plaque stabilization: can we turn theory into evidence?","volume":"98","author":"Libby","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2009.09.010_bib21","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1161\/01.CIR.103.2.276","article-title":"An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro","volume":"103","author":"Aikawa","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2009.09.010_bib22","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/MNH.0b013e3280148e4f","article-title":"Small GTP-binding proteins and mitogen-activated protein kinases as promising therapeutic targets of vascular remodeling","volume":"16","author":"Shirai","year":"2007","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.jacc.2009.09.010_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2005.04.023","article-title":"Rho and vascular disease","volume":"183","author":"Rolfe","year":"2005","journal-title":"Atherosclerosis"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109709030861?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109709030861?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:35:40Z","timestamp":1760013340000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109709030861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":23,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0735109709030861"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2009.09.010","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of Intensive Statin Therapy on Clinical Outcomes Among Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2009.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}